Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-04-10
1999-01-12
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514352, 546309, 546337, A61K 3144, C07D21172, C07D21184, C07D21170
Patent
active
058590331
ABSTRACT:
A series of pyridinyl tri-substituted benzamide derivatives of general structure ##STR1## wherein the symbols R.sup.1, R.sup.2, X and n are described in detail in the specification, are useful as anticonvulsants agents.
REFERENCES:
patent: 3252986 (1966-05-01), Gadekar
patent: 4093734 (1978-06-01), Kruger et al.
patent: 4684748 (1987-08-01), Robertson
patent: 4981866 (1991-01-01), Beedle et al.
Metz, et al., "Cloxacepride and Related Compounds: A New Series of Orally Active Antiallergic Compounds," J. Med. Chem., 1983, 26/Jul., pp. 1065-1070.
Ortiz Astrid
Takaki Katherine S.
Watson Brett T.
Bristol--Myers Squibb Company
Jarvis William R. A.
Ryan Richard P.
LandOfFree
Anticonvulsant pyridinyl benzamide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anticonvulsant pyridinyl benzamide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anticonvulsant pyridinyl benzamide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1516360